What is the primary concern when a patient has a history of liver disease regarding medications?

What is the primary concern when a patient has a history of liver disease regarding medications?

• A. It affects the rate of drug absorption.
• B. It significantly affects drug metabolism.
• C. It has no impact on drug therapy.
• D. It only alters drug excretion.

Answer: (B)

The key concept is that liver disease primarily disrupts drug metabolism. The liver houses the enzymes that chemically modify most medications (Phase I and Phase II reactions). When hepatic function is impaired, these metabolic pathways work less efficiently, so drugs are cleared more slowly from the body and their half-lives lengthen. This leads to higher overall exposure and a greater risk of toxicity, especially for drugs with narrow therapeutic indices. Because of reduced metabolism, clinicians often need to start at lower doses or extend dosing intervals and may monitor drug levels or patient response closely. Absorption can be affected in some cases, and some drug excretion involves the liver, but the most significant and consistent issue with liver disease is the diminished ability to metabolize medications.

The key concept is that liver disease primarily disrupts drug metabolism. The liver houses the enzymes that chemically modify most medications (Phase I and Phase II reactions). When hepatic function is impaired, these metabolic pathways work less efficiently, so drugs are cleared more slowly from the body and their half-lives lengthen. This leads to higher overall exposure and a greater risk of toxicity, especially for drugs with narrow therapeutic indices. Because of reduced metabolism, clinicians often need to start at lower doses or extend dosing intervals and may monitor drug levels or patient response closely. Absorption can be affected in some cases, and some drug excretion involves the liver, but the most significant and consistent issue with liver disease is the diminished ability to metabolize medications.